Clinical Trial Update: Trial to Evaluate Efficacy of Olanzapine With Short-acting 5HT3 Inhibitors in Chemotherapy-induced Nausea & Vomiting (CINV) Prophylaxis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating whether adding olanzapine to short-acting 5-HT3 inhibitors improves prevention of chemotherapy-induced nausea and vom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: Blokhin's Russian Cancer Research Center | Conditions: Emesis, Vomiting | Phase 2 | Status: UNKNOWN